Selectis Health, Inc.
GBCS
$1.51
-$0.49-24.50%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | 161.00K | 160.30K |
| Total Other Revenue | 10.49M | 10.40M | 10.02M | 9.42M | 9.33M |
| Total Revenue | 10.49M | 10.40M | 10.02M | 9.58M | 9.49M |
| Cost of Revenue | 8.08M | 7.87M | 7.57M | 7.42M | 7.50M |
| Gross Profit | 2.41M | 2.53M | 2.44M | 2.17M | 1.99M |
| SG&A Expenses | 2.46M | 2.27M | 3.24M | 2.52M | 2.26M |
| Depreciation & Amortization | 363.00K | 362.70K | 374.10K | 409.50K | 423.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.91M | 10.50M | 11.19M | 10.35M | 10.19M |
| Operating Income | -421.70K | -97.30K | -1.17M | -763.90K | -696.30K |
| Income Before Tax | -656.00K | -576.50K | -1.61M | 794.30K | -1.03M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -656.00K | -576.50K | -1.61M | 794.30K | -1.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -656.00K | -576.50K | -1.61M | 794.30K | -1.03M |
| EBIT | -421.70K | -97.30K | -1.17M | -763.90K | -696.30K |
| EBITDA | -58.70K | 265.50K | -797.60K | -354.40K | -272.70K |
| EPS Basic | -0.22 | -0.19 | -0.53 | 0.26 | -0.34 |
| Normalized Basic EPS | -0.13 | -0.13 | -0.33 | -0.27 | -0.21 |
| EPS Diluted | -0.22 | -0.20 | -0.53 | 0.26 | -0.34 |
| Normalized Diluted EPS | -0.13 | -0.13 | -0.33 | -0.27 | -0.21 |
| Average Basic Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.07M |
| Average Diluted Shares Outstanding | 3.07M | 3.07M | 3.07M | 3.07M | 3.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |